OC.57 Safety and efficacy of CD19 NEX-T® (BMS-986353), a chimeric antigen receptor (CAR) T cell therapy, in systemic sclerosis (SSc): findings from the breakfree-1 trial
Oral Communications | June 5, 2026 | Volume: No volume available | Issue: No issue available | Pages: A61-A63
10.1136/jsrd-2026-sswc.57